Nomura Holdings Proposes Director Appointments Amidst Governance Enhancements

Nomura Holdings ( (NMR) ) just unveiled an announcement.

On June 4, 2025, Nomura Holdings announced its proposal for the appointment of twelve directors at the upcoming Annual General Meeting. Despite Institutional Shareholder Services advising against the reappointment of two directors due to past compliance issues, Nomura’s Nomination Committee supports them, citing their contributions and the company’s enhanced governance measures. The company has implemented corrective actions following past incidents, including strengthening internal controls and compliance frameworks. Nomura also reported a record high net income for the fiscal year ending March 2025 and announced the acquisition of Macquarie Group’s US and European public asset management business, aligning with its long-term growth strategy.

Spark’s Take on NMR Stock

According to Spark, TipRanks’ AI Analyst, NMR is a Neutral.

Nomura Holdings demonstrates strong growth and operational efficiency with a robust revenue increase and high EBIT margin. However, financial risks from high leverage and negative cash flow, coupled with technical indicators showing potential bearish trends, balance the positive valuation metrics and strategic initiatives from the earnings call. The stock’s low P/E ratio and healthy dividend yield make it attractive for value investors, but caution is advised due to financial and market volatility.

To see Spark’s full report on NMR stock, click here.

More about Nomura Holdings

Nomura Holdings, Inc. is a prominent financial services group based in Tokyo, Japan, providing a wide range of financial services including investment banking, asset management, and securities trading. The company is known for its strong presence in the Japanese market and its strategic initiatives to expand globally, particularly in the US and European markets.

Average Trading Volume: 820,998

Technical Sentiment Signal: Strong Buy

Current Market Cap: $18.07B

For an in-depth examination of NMR stock, go to TipRanks’ Stock Analysis page.